Barclays Cuts Huntington Bancshares (NASDAQ:HBAN) Price Target to $12.00
Huntington Bancshares (NASDAQ:HBAN – Free Report) had its price objective trimmed by Barclays from $13.00 to $12.00 in a research report report published on Monday, Benzinga reports. They currently have an underweight rating on the bank’s stock. Several other analysts have also recently weighed in on HBAN. Jefferies Financial Group decreased their price objective on […]
More Stories
Fidelity Fundamental Small-Mid Cap ETF (BATS:FSMO) Stock Price Crosses Above 200 Day Moving Average – Here’s Why
Fidelity Fundamental Small-Mid Cap ETF (BATS:FSMO – Get Free Report) shares crossed above its 200-day moving average during trading on...
iShares iBonds Dec 2026 Term Muni Bond ETF (BATS:IBMO) Share Price Pass Above Two Hundred Day Moving Average – Should You Sell?
iShares iBonds Dec 2026 Term Muni Bond ETF (BATS:IBMO – Get Free Report) crossed above its 200-day moving average during...
Cheetah Canyon Resources (CVE:CHTA) Share Price Passes Below 200 Day Moving Average – Time to Sell?
Shares of Cheetah Canyon Resources (CVE:CHTA – Get Free Report) crossed below its 200-day moving average during trading on Thursday...
ProShares K-1 Free Crude Oil ETF (BATS:OILK) Share Price Cross Below 200-Day Moving Average – Here’s What Happened
ProShares K-1 Free Crude Oil ETF (BATS:OILK – Get Free Report) shares passed below its 200-day moving average during trading...
Euclid Capital Growth ETF (BATS:EUCG) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?
Shares of Euclid Capital Growth ETF (BATS:EUCG – Get Free Report) passed above its 200-day moving average during trading on...
Merck & Co., Inc. (NYSE:MRK) Position Boosted by Leelyn Smith LLC
Leelyn Smith LLC raised its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 2.6% during...